
StudyFinder
Efficacy/Safety SPR001 (Tildacerfont) Reducing Supraphysiologic Glucocorticoid Use in Adults w CAH

OPEN TO ACCRUAL
drug: Spr001 (tildacerfont)
Endocrine, Nutritional, Metabolic Diseases, Immunity Disorders (240-279)
Memoli, Erica, H - erica.memoli@vcuhealth.org
Gupta, Anshu
II
HM20019420
NCT04544410
See this study on ClinicalTrials.gov